SightfileU.S. market data from official filings

OMADA HEALTH INC (OMDA)

Name: OMADA HEALTH INC (OMDA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001611115 · EDGAR filings · Updated 2026-07-20

OMADA HEALTH INC (OMDA) has reported institutional ownership of 81.7%, with 139 institutional managers holding positions valued at $605.1M per the latest 13F reporting period.

Institutional ownership

81.7%

Institutional managers

139

Reported 13F value

$605.1M

Insider activity

58 trans.

−$4.63M net selling

Latest updates

2026-07-20 — 4/A filed
2026-07-17 — Insider transaction reported (Form 4)
2026-07-15 — Insider transaction reported (Form 4)
2026-07-15 — Insider transaction reported (Form 4)
2026-07-15 — Notice of proposed sale filed (Form 144)
2026-07-13 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OMADA HEALTH INC has 139 institutional holders and institutional ownership of 81.7%.

Insider activity

Insiders reported 58 transactions (0 buys, 9 sells) across 14 reporting insiders, with a net reported value of −$4.63M.

Related companies

REPLIMUNE GROUP INC (REPL) · STEVANATO GROUP S P A (STVN) · XERIS BIOPHARMA HOLDINGS INC (XERS) · BIOAGE LABS INC (BIOA) · MEIRAGTX HLDGS PLC (MGTX) · RELMADA THERAPEUTICS INC (RLMD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.